AUTHYNTI Trademark

Trademark Overview


On Wednesday, June 21, 2023, a trademark application was filed for AUTHYNTI with the United States Patent and Trademark Office. The USPTO has given the AUTHYNTI trademark a serial number of 98053889. The federal status of this trademark filing is PUBLICATION/ISSUE REVIEW COMPLETE as of Wednesday, September 11, 2024. This trademark is owned by Gilead Sciences Ireland UC. The AUTHYNTI trademark is filed in the Pharmaceutical Products category with the following description:

Antiviral pharmaceutical preparations; anti-infective pharmaceutical preparations; anti-fibrotic pharmaceutical preparations; pharmaceutical preparations for treatment and prevention of HIV infection; pharmaceutical preparations for the treatment of liver diseases and disorders; pharmaceutical preparations for the treatment of hematological diseases and disorders; pharmaceutical preparations for the treatment of oncological diseases and disorders; pharmaceutical preparations for the treatment of inflammatory diseases and disorders; pharmaceutical preparations for the treatment of autoimmune diseases and disorders; pharmaceutical preparations for the treatment of respiratory and pulmonary diseases and disorders; pharmaceutical preparations for the treatment of kidney and nephropathic diseases and disorders; pharmaceutical preparations for the treatment of arthritis; pharmaceutical preparations for treatment of gastrointestinal diseases and disorders
authynti

General Information


Serial Number98053889
Word MarkAUTHYNTI
Filing DateWednesday, June 21, 2023
Status681 - PUBLICATION/ISSUE REVIEW COMPLETE
Status DateWednesday, September 11, 2024
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, October 15, 2024

Trademark Statements


Goods and ServicesAntiviral pharmaceutical preparations; anti-infective pharmaceutical preparations; anti-fibrotic pharmaceutical preparations; pharmaceutical preparations for treatment and prevention of HIV infection; pharmaceutical preparations for the treatment of liver diseases and disorders; pharmaceutical preparations for the treatment of hematological diseases and disorders; pharmaceutical preparations for the treatment of oncological diseases and disorders; pharmaceutical preparations for the treatment of inflammatory diseases and disorders; pharmaceutical preparations for the treatment of autoimmune diseases and disorders; pharmaceutical preparations for the treatment of respiratory and pulmonary diseases and disorders; pharmaceutical preparations for the treatment of kidney and nephropathic diseases and disorders; pharmaceutical preparations for the treatment of arthritis; pharmaceutical preparations for treatment of gastrointestinal diseases and disorders

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateTuesday, July 25, 2023
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameGilead Sciences Ireland UC
Party Type10 - Original Applicant
Legal Entity Type99 - Other
AddressCarrigtohill
IE

Trademark Events


Event DateEvent Description
Thursday, January 11, 2024ASSIGNED TO EXAMINER
Saturday, June 24, 2023NEW APPLICATION ENTERED
Tuesday, July 25, 2023NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Thursday, January 18, 2024NON-FINAL ACTION WRITTEN
Thursday, January 18, 2024NON-FINAL ACTION E-MAILED
Thursday, January 18, 2024NOTIFICATION OF NON-FINAL ACTION E-MAILED
Wednesday, April 17, 2024TEAS RESPONSE TO OFFICE ACTION RECEIVED
Tuesday, September 10, 2024CORRESPONDENCE RECEIVED IN LAW OFFICE
Tuesday, September 10, 2024TEAS/EMAIL CORRESPONDENCE ENTERED
Tuesday, September 10, 2024APPROVED FOR PUB - PRINCIPAL REGISTER
Tuesday, September 10, 2024ASSIGNED TO LIE
Wednesday, September 25, 2024NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED